1. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial. Issue 9 (September 2018) Authors: Kim, Youn H; Bagot, Martine; Pinter-Brown, Lauren; Rook, Alain H; Porcu, Pierluigi; Horwitz, Steven M; Whittaker, Sean; Tokura, Yoshiki; Vermeer, Maarten; Zinzani, Pier Luigi; Sokol, Lubomir; Morris, Stephen; Kim, Ellen J; Ortiz-Romero, Pablo L; Eradat, Herbert; Scarisbrick, Julia; Tsianakas, Ath... Journal: Lancet oncology Issue: Volume 19:Issue 9(2018) Page Start: 1192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinician-level variation in mechlorethamine treatment duration in mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL). (2019) Authors: Querfeld, Christian; Pacheco, Theresa; Haverkos, Bradley; Binder, Gary; Angello, James; Poligone, Brian Journal: European journal of cancer Issue: Volume 119(2019)Supplement 1 Page Start: S8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long‐term disease control and safety with the anti‐CCR4 antibody mogamulizumab: Post‐hoc analyses from the MAVORIC trial of patients with previously treated cutaneous T‐cell lymphoma. Issue 8 (28th June 2022) Authors: Bagot, Martine; Dalle, Stéphane; Sokol, Lubomir; Tsianakas, Athansios; Musiek, Amy; Ortiz‐Romero, Pablo L.; Poligone, Brian; Duvic, Madeleine; Elmets, Craig; Leoni, Mollie; Dwyer, Karen; Ito, Takahiro; Herr, Fiona; Kim, Youn H. Journal: Dermatologic therapy Issue: Volume 35:Issue 8(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PKK deletion in basal keratinocytes promotes tumorigenesis after chemical carcinogenesis. (22nd November 2017) Authors: Chen, Luojing; Hayden, Matthew S; Gilmore, Elaine S; Alexander-Savino, Carolina; Oleksyn, David; Gillespie, Kathleen; Zhao, Jiyong; Poligone, Brian Journal: Carcinogenesis Issue: Volume 39:Number 3(2018) Page Start: 418 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Relief of intractable pruritus with romidepsin in patients with cutaneous T‐cell lymphoma: A series of four cases. Issue 2 (4th January 2019) Authors: Poligone, Brian; Rubio‐Gonzalez, Belen; Querfeld, Christiane Journal: Dermatologic therapy Issue: Volume 32:Issue 2(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗